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Kinase regulationa b s t r a c t
The Ca2+/calmodulin-dependent protein kinase II (CaMKII) mediates physiological and pathological
functions by its Ca2+-independent autonomous activity. Two novel mechanisms for generating
CaMKII autonomy include oxidation and S-nitrosylation, the latter requiring both Cys280 and
Cys289 amino acid residues in the brain-speciﬁc isoform CaMKIIa. Even though the other CaMKII
isoforms have a different amino acid in the position homologous to Cys280, we show here that nitric
oxide (NO)-signaling generated autonomy also for the CaMKIIb isoform. Furthermore, although
oxidation of the Met280/281 residues is sufﬁcient to generate autonomy for most CaMKII isoforms,
oxidation-induced autonomy was also prevented by a Cys289-mutation in the CaMKIIa isoform.
Thus, all CaMKII isoforms can be regulated by physiological NO-signaling, but CaMKIIa regulation
by oxidation and S-nitrosylation is more stringent.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A hallmark feature of CaMKII regulation is the generation of
Ca2+-independent ‘‘autonomous’’ kinase activity by T286 auto-
phosphorylation [1–4], a processes considered to be a form of
molecular memory and indeed important for induction of long-
term changes in synaptic strength [5–7] (for review see [8,9]). Sev-
eral additional ways to generate CaMKII autonomy have been
described more recently, including by GluN2B binding [10,11], by
O-linked glycosylation [12], by oxidation [13] and by S-nitrosyla-
tion [14]. In this study, the two latter mechanisms were examined
further. For both oxidation and S-nitrosylation of CaMKII,
important pathological functions have been indicated: oxidation
of CaMKIId (the dominant isoform in the heart) is involved in
important pathological functions in the heart [13], while
NO-induced S-nitrosylation of CaMKIIa (the dominant isoform in
the brain) appears to contribute to ischemic/excitotoxic neuronal
cell death [14]. S-nitrosylation of CaMKII may also contribute tophysiological NO-signaling, but such possible functions remain to
be elucidated. Like T286 autophosphorylation, autonomous CaMKII
activity generated by oxidation or S-nitrosylation requires an ini-
tial Ca2+/CaM stimulus [13,14], likely to make the relevant residues
within the regulatory domain accessible for modiﬁcation (Fig. 1).
Three residues are of interest for autonomy induced by oxidation
or S-nitrosylation: C280/M281 and C289 in CaMKIIa, which are
homologous to M281/M282 and C290 in the other CaMKII iso-
forms, b, c, and d (Fig. 1). Oxidation-induced autonomy of CaMKIId
was abolished by M281/M282V mutation (and mildly reduced by
individual mutation of either site), but was not sensitive to
C290V mutation [13]. Oxidation also generated autonomy of CaM-
KIIa [13,14] and of a CaMKIId mutant with the CaMKIIa regulatory
domain sequence (generated by M281C mutation) [13]. The latter
results were expected, as both Met and Cys residues can be oxi-
dized. By contrast, S-nitrosylation can occur only at Cys but not
at Met residues. While nitrosylation-induced autonomy of CaM-
KIIa required C289 (homologous to C290 in the other isoforms),
it additionally required C280 (which is replaced by M281 in the
other isoforms) [14]. This indicates that oxidation could induce
autonomy for all CaMKII isoforms, but that S-nitrosylation would
induce autonomy only for the CaMKIIa isoform. However, as NO
can additionally cause protein oxidation via formation of ONOO,
NO-signaling may also regulate other CaMKII isoforms.
Fig. 1. CaMKII structure and regulation in schematic representation. (A) CaMKII forms 12 meric holoenzymes with the N-terminal kinase domains (blue) radiating outward
from a central hub formed by the C-terminal association domains (acqua). Each kinase subunit is stimulated separately by Ca2+/CaM binding to the regulatory domain (green),
but Ca2+/CaM binding to two neighboring subunits is required to trigger an inter-subunit autophosphorylation at T287 (red; for the a isoform T286) that generates by Ca2+-
independent ‘‘autonomous’’ activity. (B) In the basal state, the regulatory domain blocks substrate access to the S-site (orange) and is held in place in part by interaction of the
region around T287 with the T-site (yellow). C290 and M281 are homologous to residues that are involved in nitrosylation- or oxidation-induced autonomy of CaMKIIa. The
corresponding modiﬁcations of the indicated residues likely prevent complete re-binding of the regulatory domain to the kinase domain. (C) The sequence of the N-terminal
part of the regulatory domain of the different CaMKII isoforms. The oxidation sites (Met, Cys), nitrosylation sites (Cys), and the T286/287 phosphorylation site are marked in
bold; the two Cys residues required for nitrosylation in CaMKIIa and the homologous residues in the other isoforms are marked by gray shading.
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mediated regulation of CaMKIIb, the second brain-enriched CaMKII
isoform. Notably, CaMKIIb has several important isoform-speciﬁc
functions in the brain that are not shared by the a isoform
[15–17]; these differential functions have been attributed to the
b-speciﬁc interaction with F-actin [15,16,18]. As expected, we
found that NO and oxidation induced autonomy also for CaMKIIb.
However, more surprisingly, CaMKIIb autonomy was generated
by NO even when oxidation was suppressed. Thus, even CaMKII
isoforms that contain C290 but lack a Cys in position 281 (i.e. all
isoforms except for a) can be directly regulated by nitrosylation.
This indicates that all CaMKII isoforms can be regulated not only
by pathological oxidation but also by physiological NO-signaling.
2. Materials and methods
2.1. Proteins
CaMKIIa and b wild type isoforms and CaM were puriﬁed after
baculovirus/Sf9 cell expression or bacterial expression as previ-
ously described [4,19]. For CaMKIIb puriﬁcation, the cell extraction
buffer was supplemented with 150 mM NaClO4 prior to centrifuga-
tion, in order to improve solubility of the cytoskeleton-associated
isoform [19]. For comparison of CaMKIIa wild type and mutants,
GFP-CaMKII fusion proteins were puriﬁed after expression in HEK
cells as previously described [14,20]. For comparison of the
CaMKIIb mutants, GFP-CaMKII fusion proteins in HEK cell extract
were used, after adjustments for content of total cellular protein
as previously described [14]. Crude HEK cell extracts were spun
at 4 C at 20,000g for 20 min. Then, GFP-CaMKIIb was solubilized
from the pellets using 1.2 M KCl [21] .2.2. CaMKII nitrosylation and oxidation
CaMKII nitrosylation or oxidation was performed as previously
described [14]. CaMKII (200–300 nM subunit concentration) was
reacted in buffer containing 50 mM PIPES pH 7.1, 1 mM CaCl2,
and 1 lM CaM either with 3 mM DEA-NONOate (Cayman Chemi-
cals; for nitrosylation) or with 3 mM H2O2 (Sigma; for oxidation).
DEA-NONOate is stable in low pH buffers, but rapidly releases
NO when added to the pH 7.1 reaction buffer [14]. When indicated,
the nitrosylation reactions also contained the ONOO-scavengers
tryptophan (3 mM; Sigma) or MnTMPyP (0.3 mM; A.G. Scientiﬁc).
After 5 min at room temperature, the reactions were diluted and
Ca2+ was chelated with 5 mM EGTA.
2.3. CaMKII activity assays
CaMKII activity was determined by 32P incorporation into the
peptide substrate syntide 2 (Genescript) as previously described
[4,14,19]. In order to assess basal or autonomous CaMKII activity,
reactions contained 2.5 nM CaMKII, 50 mM PIPES pH 7.1, 0.1%
bovine serum albumin, 10 mM MgCl2, 100 lM [c-32P]ATP
(1 mCi/lmol), 75 lM substrate peptide, and 1.5 mM EGTA. In
order to determine the relative level of autonomy (the ratio of
autonomous over maximally stimulated activity), stimulated reac-
tions were performed in the same buffer, but with EGTA substi-
tuted by Ca2+/CaM (1 mM/2 lM). Reactions were performed at
30 C for a duration that ensured that they were within the linear
range (1 min for maximally stimulated activity, 5 min for nitrosy-
lation- or oxidation-induced autonomous activity) [4,14].
For measuring the activity of GFP-CaMKIIb wild type and
mutants, the PIPES in the reaction buffer was replaced with
4674 S.J. Coultrap et al. / FEBS Letters 588 (2014) 4672–467650 mM HEPES pH 7.4 and 150 mM KCl (as KCl was required for
extraction from the cytoskeletal fraction).
3. Results
3.1. NO generated autonomous activity of the C280-lacking CaMKIIb
isoform
NO induces autonomyof the CaMKIIa isoformvia S-nitrosylation
at C280 and C289, and autonomy was abolished by mutation of
either residue [14]. Like CaMKIIc and d, the CaMKIIb isoform con-
tains M281 at the position homologous to C280 (Fig. 1), a residue
that cannot be S-nitrosylated. However, addition of the NO-donor
DEA-NONOate to CaMKIIb (in the presence of Ca2+/CaM) also gener-
ated autonomous activity for this C280-lacking isoform, as mea-
sured in a kinase activity assay after chelation of Ca2+ (Fig. 2). The
level of autonomy induced by NO was similar for the CaMKIIa and
b isoforms, but slightly higher for CaMKIIb (Fig. 2A). The maximal
Ca2+/CaM-stimulated kinase activity was slightly reduced by the
5 min NO treatment for the CaMKIIa but not the b isoformFig. 2. Both NO and H2O2 induce autonomous CaMKIIb activity. CaMKIIb or a was
reacted for 5 min in presence of Ca2+/CaM in presence or absence of the NO-donor
DEA-NONOate (NO) or H2O2 as indicated. Then, activity was measured by
phosphate incorporation into the substrate peptide syntide 2. (A) Autonomous
activity was measured after chelation of Ca2+ with EGTA, and is represented here as
the percent autonomy compared to the maximal Ca2+/CaM-stimulated activity.
Both NO and H2O2 induced signiﬁcant autonomous activity for both CaMKIIb and a.
For both isoforms, the NO-induced autonomy was signiﬁcantly greater than the
H2O2-induced autonomy. (B) Maximal stimulated activity was measured in
presence of Ca2+/CaM. The treatments did not affect stimulated activity of CaMKIIb,
while CaMKIIa activity was mildly but signiﬁcantly reduced by the NO treatment.
Bar graphs indicate mean ± S.E.M. in all panels (n = 4; ⁄P < 0.01; ⁄⁄P < 0.001;
compared to no treatment or as indicated, in ANOVA with Neuman–Keuls posthoc
analysis).(Fig. 2B). Note that in a previous study, NO treatment for 5 min did
not signiﬁcantly reduce stimulated CaMKIIa activity either, while
NO treatments for 10 min or longer reduced the activitymuchmore
substantially [14].
In summary, while CaMKIIa requires C280 for S-nitrosylation-
induced autonomy [14], the C280-lacking CaMKIIb does not.
3.2. Oxidation induced autonomous activity of the CaMKIIb isoform
Oxidation of CaMKIIa or d (induced by addition H2O2 in the pres-
ence of Ca2+/CaM) is another pathway to induce autonomous CaM-
KII activity [13,14]. The same oxidizing treatment also induced
autonomous activity of the CaMKIIb isoform (Fig. 2A). This result
was expected, as CaMKIIb has a regulatory domain sequence that
is identical to CaMKIId (see Fig. 1), including theM281/282 residues
that are necessary and sufﬁcient for the oxidation-induced auton-
omy of CaMKIId. As previously observed for CaMKIIa [14], the CaM-
KIIb autonomy induced by the H2O2 treatmentwas lower compared
to the NO treatment (Fig. 2A). However, for the CaMKIIb isoform,
this difference appeared to be less pronounced (Fig. 2A). The H2O2
treatment did not affect the maximal Ca2+/CaM-stimulated kinase
activity for either isoform (Fig. 2B).
3.3. NO generated CaMKIIb autonomy even when oxidation was
suppressed
In addition to directly causing S-nitrosylation, NO can also indi-
rectly lead to oxidation via formation of ONOO. In order to deter-
mine if the NO-induced CaMKIIb autonomy was oxidation-
dependent, conditions to suppress oxidation were tested. This
was done by adding the NO-donor together with either one of
two different ONOO-scavengers, tryptophane (Trp) or MnTMPyP
(MnTP). Note that these scavengers do not directly affect CaMKII
activity, i.e. when they are added to the kinase assays after gener-
ation of autonomy by NO-donors [14]. As previously described for
CaMKIIa [14], scavenger addition during the incubation with NO
did not reduce but instead even enhanced NO-induced CaMKIIb
autonomy (Fig. 3). This is consistent with suppression of oxidation
of C290 promoting its S-nitrosylation, which generated a higher
level of autonomy. Thus, NO-induced CaMKIIb autonomy does
not require ONOO-mediated oxidation of M281/282. As CaMKIIbFig. 3. NO induces autonomous CaMKIIb activity even when oxidation is sup-
pressed. CaMKIIb or awas reacted with NO-donor (NO) as in Fig. 2. However, where
indicated, the ONOO-scavengers tryptophane (Trp) or MnTMPyP (MnT), in order to
suppress any oxidation that could be caused by ONOO-generation. Then auton-
omous activity was measure after chelation of Ca2+ with EGTA, and the resulting
activity was normalized to the autonomy calculated in Fig. 2. For both CaMKII
isoforms, the scavengers did not reduce but instead enhanced the autonomous
activity generated by NO (n = 8 for CaMKIIbwith treatment; n = 4 for untreated and
CaMKIIa; ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001; compared to NO-treated kinase, in
ANOVA with Neuman–Keuls posthoc analysis). Bar graphs indicate mean ± S.E.M.
Fig. 4. NO-induced CaMKIIb autonomy requires C290. (A) As expected, C290M or
C290V mutation does not reduce the maximal Ca2+/CaM-stimulated activity of GFP-
CaMKIIb. If any, stimulated activity was slightly (and statistically signiﬁcantly)
greater for the mutants. (B) C290M and C290V mutation dramatically reduced NO-
induced autonomy of GFP-CaMKIIb (n = 4; ⁄⁄P < 0.001; compared to wild type
kinase, in ANOVA with Neuman–Keuls posthoc analysis). Bar graphs indicate
mean ± S.E.M. in all panels.
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autonomy of CaMKIIa, this indicates that S-nitrosylation of a single
residue, C290, is sufﬁcient for NO-induced CaMKIIb autonomy.
3.4. NO-induced CaMKIIb autonomy was sensitive to C290-mutation
In order to determine the involvement of C290 in NO-induced
CaMKIIb autonomy, we tested the effect of C290 mutation to Val
or Met. Both mutations prevent NO-induced S-nitrosylation, but
only the Val mutation additionally prevents oxidation. The C290
mutations did not reduce the maximal Ca2+/CaM-stimulated activ-
ity of CaMKIIb (Fig. 4A). If any, stimulated activity of the mutants
was slightly higher (a difference that could be due to the individual
kinase preparation or could be caused by slightly reduced autoin-
hibitory interactions). By contrast, both C290V and C290 M muta-
tion dramatically reduced the NO-induced autonomous activity
(Fig. 4B). These results strongly indicate that NO-induced CaMKIIb
autonomy requires S-nitrosylation at C290.
3.5. Oxidation-induced CaMKIIa autonomy was sensitive to C289-
mutation
Together with previous results [14], the results described above
indicated that the requirements for generation of autonomous
activity by S-nitrosylation are more stringent for CaMKIIa (requir-
ing both C280 and C289) than for the other isoforms (which lack
C280). Thus, we decided to test whether or not CaMKIIa may alsoFig. 5. Oxidation-induced CaMKIIa autonomy is sensitive not only to C280/M281
but also C289 mutation. GFP-CaMKIIa wild type or mutants were reacted with NO-
donor (NO) or H2O2 as in Fig. 2. Autonomous activity was measure after chelation of
Ca2+ with EGTA. As described previously for NO-induced CaMKIIa autonomy, the
H2O2-induced autonomy was sensitive not only to C280/M281 mutation, but also to
C289 mutation. Thus, both NO- and H2O2-induced autonomy have more stringent
requirements in CaMKIIa than in the other isoforms (n = 4–5; ⁄⁄P < 0.001; compared
to wild type, in ANOVA with Neuman–Keuls posthoc analysis). Bar graphs indicate
mean ± S.E.M.have more stringent requirements than other isoforms for
autonomy generation by oxidation. For oxidation-induced CaMKIId
autonomy, oxidation of M281/282 is sufﬁcient, and oxidation of
C290 (the residue homologous to C289 in the a isoform; see
Fig. 1) is not required [13]. By contrast, oxidation-induced CaMKIIa
autonomy was abolished not only by C280/M281V mutation, but
also by C289V mutation (Fig. 5). Thus, while oxidation of M281/
282 is sufﬁcient to generate autonomy of other CaMKII isoforms,
CaMKIIa requires simultaneous oxidation at both C280/M281
and C289 for oxidation-induced autonomy.4. Discussion
This study indicates that S-nitrosylation can generate autono-
mous (Ca2+/CaM-independent) activity for all CaMKII isoforms.
This was somewhat surprising, because the brain CaMKIIa isoform
required simultaneous S-nitrosylation at both C280 and C289 [14],
and the other CaMKII isoforms contain a Methionine instead of
C280. However, the results of this study demonstrate that the
CaMKIIb isoform can also be made autonomous by S-nitrosylation.
Initially, we hypothesized that this NO-induced autonomy may
require oxidation (via NO-dependent formation of ONOO) of the
Methionine homologous to C280. However, NO was able to induce
even higher autonomy when such oxidation was suppressed.
While CaMKIIa expression is restricted to the brain, other CaMKII
isoforms have important functions also in other tissues, including
in the heart [13,22,23]. For heart CaMKII, important pathological
functions are mediated by CaMKII autonomy generated by oxida-
tion [13]. This study indicates that all CaMKII isoforms can be made
autonomous also by NO-signaling, which can be generated patho-
logically or physiologically.
Our results indicate that generation of autonomy by S-nitrosy-
lation has a more stringent requirement for the CaMKIIa isoform
(requiring simultaneous nitrosylation of C280 and C289) compared
to the other isoform (which contain C290 that is homologous to
C289 in a, but lack a Cys homologous to C280; see Fig. 1). Thus,
while the kinase and regulatory domains of all CaMKII isoforms
are highly homologous, the CaMKIIa regulatory domain may have
a stronger auto-inhibitory interaction with its kinase domain. We
argued that, in this case, CaMKIIa may also have a more stringent
requirement for generation of autonomy by oxidation. Indeed,
while oxidation of the residues homologous to CaMKIIa C280/
M281 is sufﬁcient to generate autonomous activity for heart CaM-
KIId [13], the oxidation-induced autonomy of CaMKIIa was abol-
ished by mutation of either C280/M281 or C289, indicating that
simultaneous oxidation of all three residues was required. Thus,
the brain-speciﬁc CaMKIIa is more tightly controlled than other
isoforms in regard to generation of autonomous activity by both
S-nitrosylation and oxidation. Pathological functions of oxidation
and S-nitrosylation have been described for both heart and brain
CaMKII [13,14]. As NO-induced S-nitrosylation can occur during
both pathological and physiological signaling [24,25], it will be
interesting to determine also such physiological functions of CaM-
KII regulation by NO. For brain CaMKIIa, this may include functions
in both potentiation and depression of synaptic strength [7].
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